StockData

Yarrow Bioscience, Inc. (YARW) stock

YARWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/30102% above fair value
$14.35+0.14 (+0.99%)

Close on Nov 18, 2026Market cap $38.31MP/E –Yield –

Yarrow Bioscience pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Yarrow Bioscience's pe ratio was 0.6× on Apr 30, 2021, against 0.6× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2021Apr 30, 20210.6×−1.9
2020Dec 31, 20202.5×−2.2
2019Dec 31, 20194.6×–

More Yarrow Bioscience figures

See a number that looks wrong?